Sitemap > Breaking Research > Infectious Diseases
Displaying 351 - 400 of 4290 results
- Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.
- A database of recombinant viruses and recombinant viral vectors available from the RIKEN DNA bank.
- Th1-orientated immunological properties of the bacterial extract OM-85-BV.
- Complete replication of hepatitis C virus in cell culture.
- Influenza vaccination is associated with a reduced risk of stroke.
- Leukotriene inhibitors in combination with steroids: potential role in the development of primary bacterial peritonitis.
- Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.
- Synthesis of cationic beta-vinyl substituted meso-tetraphenylporphyrins and their in vitro activity against herpes simplex virus type 1.
- Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
- Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model.
- Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen: a novel approach for inducing recognition of new viral epitopes.
- Antileishmanial activity of HIV protease inhibitors.
- Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site.
- The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.
- Evasion of Toll-like receptor 5 by flagellated bacteria.
- Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
- comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
- Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.
- Novel nuclear export signal-interacting protein, NESI, critical for the assembly of hepatitis delta virus.
- Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.
- Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.
- Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract.
- Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia.
- Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.
- Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.
- The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial.
- Dual effects of extracellular adherence protein from Staphylococcus aureus on peripheral blood mononuclear cells.
- IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes.
- Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery.
- Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors.
- Development of a transposon-based approach for identifying novel transgene insertion sites within the replicating adenovirus.
- Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
- Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection.
- Cell-based assays to detect inhibitors of fungal mRNA capping enzymes and characterization of sinefungin as a cap methyltransferase inhibitor.
- High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands.
- A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.
- P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats.
- Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
- Cytotoxic, antiviral (in-vitro and in-vivo), immunomodulatory activity and influence on mitotic divisions of three taxol derivatives: 10-deacetyl-baccatin III, methyl (N-benzoyl-(2'R,3'S)-3'-phenylisoserinate) and N-benzoyl-(2'R,3'S)-3'-phenylisoserine.
- Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.
- Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.
- Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
- Identification of a novel adhesion molecule involved in the virulence of Legionella pneumophila.
- KatA, the major catalase, is critical for osmoprotection and virulence in Pseudomonas aeruginosa PA14.
- Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.
- Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria.
- Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
- First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication.
- Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 Next >